Identification
Instrument name
ELI LILLY AND COMPANY
Symbol
LLY
ISIN code
US5324571083
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
ICB
Pharmaceuticals
Activity description

<p>
Eli Lilly and Company is one of the world&rsquo;s leading pharmaceutical groups. Net sales break down by therapeutic field as follows:</p>
<ul>
<li>
neurology (33.5%): primarily drugs used in treating depression and schizophrenia;</li>
<li>
endocrinology (30.1%): products for treating osteoporosis, diabetes, and growth problems;</li>
<li>
oncology (14.5%);</li>
<li>
cardiovascular diseases (11.7%);</li>
<li>
veterinary medicine (9%);</li>
<li>
other (1.2%).</li>
</ul>
<p>
Net sales are distributed geographically as follows: the United States (54.5%), Europe (18.9%), Japan (9.9%) and other (16.7%).<br />
<sub>Source: Cofisem</sub></p>

Website address
Operation
IPO date
IPO type

<p>
Direct listing</p>

Catégorie
IPO